Causal mediation analysis with mediator values below an assay limit.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley Country of Publication: England NLM ID: 8215016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0258 (Electronic) Linking ISSN: 02776715 NLM ISO Abbreviation: Stat Med Subsets: MEDLINE
    • Publication Information:
      Original Publication: Chichester ; New York : Wiley, c1982-
    • Subject Terms:
    • Abstract:
      Causal indirect and direct effects provide an interpretable method for decomposing the total effect of an exposure on an outcome into the indirect effect through a mediator and the direct effect through all other pathways. A natural choice for a mediator in a randomized clinical trial is the treatment's targeted biomarker. However, when the mediator is a biomarker, values can be subject to an assay lower limit. The mediator is affected by the treatment and is a putative cause of the outcome, so the assay lower limit presents a compounded problem in mediation analysis. We propose two approaches to estimate indirect and direct effects with a mediator subject to an assay limit: (1) extrapolation and (2) numerical optimization and integration of the observed likelihood. Since these estimation methods solely rely on the so-called Mediation Formula, they apply to most approaches to causal mediation analysis: natural, separable, and organic indirect, and direct effects. A simulation study compares the two estimation approaches to imputing with half the assay limit. Using HIV interruption study data from the AIDS Clinical Trials Group described in Li et al 2016, AIDS; Lok and Bosch 2021, Epidemiology, we illustrate our methods by estimating the organic/pure indirect effect of a hypothetical HIV curative treatment on viral suppression mediated by two HIV persistence measures: cell-associated HIV-RNA and single-copy plasma HIV-RNA.
      (© 2024 John Wiley & Sons Ltd.)
    • References:
      Imai K, Keele L, Yamamoto T. Identification, inference and sensitivity analysis for causal mediation effects. Stat Sci. 2010;25(1):51‐71.
      Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173‐1182.
      Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 1992;3(2):143‐155.
      Pearl J. Direct and indirect effects. Paper presented at: Proceedings of UAI‐01, San Francisco, CA. 2001:411‐420.
      VanderWeele T. Explanation in Causal Inference: Methods for Mediation and Interaction. New York, NY: Oxford University Press; 2015.
      Lok JJ. Defining and estimating causal direct and indirect effects when setting the mediator to specific values is not feasible. Stat Med. 2016;35(22):4008‐4020.
      Lok JJ, Bosch RJ. Causal organic indirect and direct effects: closer to the original approach to mediation analysis, with a product method for binary mediators. Epidemiology. 2021;32(3):412‐420.
      Lyles RH, Fan D, Chuachoowong R. Correlation coefficient estimation involving a left censored laboratory assay variable. Stat Med. 2001;20(19):2921‐2933.
      Lynn HS. Maximum likelihood inference for left‐censored HIV RNA data. Stat Med. 2001;20(1):33‐45.
      Robins JM, Richardson TS. Alternative graphical causal models and the identification of direct effects. In: Shrout PE, Keyes KM, Ornstein K. eds. Causality and Psychopathology: Finding the Determinants of Disorders and their Cures. Oxford, UK: Oxford University Press; 2010:103‐158.
      Li JZ, Etemad B, Ahmed H, et al. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS. 2016;30(3):343‐353.
      Aitkin M. A note on the regression analysis of censored data. Dent Tech. 1981;23(2):161‐163.
      McCulloch CE. Maximum likelihood algorithms for generalized linear mixed models. J Am Stat Assoc. 1997;92(437):162‐170.
      Cole SR, Chu H, Nie L, Schisterman EF. Estimating the odds ratio when exposure has a limit of detection. Int J Epidemiol. 2009;38(6):1674‐1680.
      Byrd RH, Lu P, Nocedal J, Zhu C. A limited memory algorithm for bound constrained optimization. SIAM J Sci Comput. 1995;16(5):1190‐1208.
      Hill AL, Rosenbloom DI, Fu F, Nowak MA, Siliciano RF. Predicting the outcomes of treatment to eradicate the latent reservoir for HIV‐1. Proc Natl Acad Sci. 2014;111(37):13475‐13480.
      WHO. Progress report on HIV, viral hepatitis and sexually transmitted infections 2019. Accountability for the global health sector strategies, 2016–2021. Geneva: World Health Organization. 2019.
      Pitman MC, Lau JS, McMahon JH, Lewin SR. Barriers and strategies to achieve a cure for HIV. Lancet HIV. 2018;5(6):e317‐e328.
      Valeri L, Lin X, VanderWeele TJ. Mediation analysis when a continuous mediator is measured with error and the outcome follows a generalized linear model. Stat Med. 2014;33(28):4875‐4890.
      WHO. Transmission of SARS‐CoV‐2: implications for infection prevention precautions: scientific brief, 9 July 2020. Technical Report. Geneva, Switzerland: World Health Organization. 2020.
      Kim HR, An S, Hwang J. An integrated system of air sampling and simultaneous enrichment for rapid biosensing of airborne coronavirus and influenza virus. Biosens Bioelectron. 2020;170:112656. doi:10.1016/j.bios.2020.112656.
      Yildirim SA, Pekey B, Pekey H. Assessment of occupational exposure to fine particulate matter in dental prosthesis laboratories in Kocaeli, Turkey. Environ Monitor Assess. 2020;192(10):1‐16.
      Lok JJ. Organic direct and indirect effects with post‐treatment common causes of mediator and outcome. 2020. doi:10.48550/ARXIV.1510.02753.
    • Grant Information:
      UM1 AI068634 United States AI NIAID NIH HHS; UM1 AI068636 United States AI NIAID NIH HHS; UM1 AI068634 United States AI NIAID NIH HHS; UM1 AI068636 United States AI NIAID NIH HHS; DMS 1854934 Center for Hierarchical Manufacturing, National Science Foundation
    • Contributed Indexing:
      Keywords: HIV/AIDS; assay lower limit; causal inference; causal mediation analysis; indirect and direct effects
    • Publication Date:
      Date Created: 20240401 Date Completed: 20240520 Latest Revision: 20240520
    • Publication Date:
      20240520
    • Accession Number:
      10.1002/sim.10065
    • Accession Number:
      38556761